Cargando…

GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges

Detalles Bibliográficos
Autores principales: Robinson, H, Kannanganat, S, Gangadhara, S, Lai, L, Yu, T, Kozlowski, P, Earl, P, Moss, B, Amara, RR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441798/
http://dx.doi.org/10.1186/1742-4690-9-S2-P25
_version_ 1782243378666143744
author Robinson, H
Kannanganat, S
Gangadhara, S
Lai, L
Yu, T
Kozlowski, P
Earl, P
Moss, B
Amara, RR
author_facet Robinson, H
Kannanganat, S
Gangadhara, S
Lai, L
Yu, T
Kozlowski, P
Earl, P
Moss, B
Amara, RR
author_sort Robinson, H
collection PubMed
description
format Online
Article
Text
id pubmed-3441798
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34417982012-09-18 GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges Robinson, H Kannanganat, S Gangadhara, S Lai, L Yu, T Kozlowski, P Earl, P Moss, B Amara, RR Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441798/ http://dx.doi.org/10.1186/1742-4690-9-S2-P25 Text en Copyright ©2012 Robinson et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Robinson, H
Kannanganat, S
Gangadhara, S
Lai, L
Yu, T
Kozlowski, P
Earl, P
Moss, B
Amara, RR
GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
title GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
title_full GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
title_fullStr GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
title_full_unstemmed GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
title_short GM-CSF co-expressing DNA/MVA vaccine, prevention of acquisition by two series of SIVE660 challenges followed by a series of SIV251 challenges
title_sort gm-csf co-expressing dna/mva vaccine, prevention of acquisition by two series of sive660 challenges followed by a series of siv251 challenges
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441798/
http://dx.doi.org/10.1186/1742-4690-9-S2-P25
work_keys_str_mv AT robinsonh gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT kannanganats gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT gangadharas gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT lail gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT yut gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT kozlowskip gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT earlp gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT mossb gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges
AT amararr gmcsfcoexpressingdnamvavaccinepreventionofacquisitionbytwoseriesofsive660challengesfollowedbyaseriesofsiv251challenges